Down the ages the poets warned us that aging is inevitable.
But that was then. Today, developments in organ immunology in Germany have made rejuvenation therapy a reality, while offering treatment options for ailments associated with age.
In the last century, medical science understood the links between aging, disease and cell changes in the body. Once these were known, it became possible to investigate scientific ways of restoring cells, whether the damage to them had been caused by disease, injury, or “old Time a-flying.”
It is widely known in Germany that molecular cell therapy is a treatment to rejuvenate the cells of worn out or damaged organs in patients young or old. The treatment has been officially recognized as a legitimate part of medical practice in Germany for over 50 years.
In the 1930s, the centre of activity in the field of regenerating cells was in Switzerland. Then in 1953, the year that DNA was identified by Crick and Watson, the concept was revolutionized by the work of Karl Theurer in Germany, and the holistic form of bio-molecular therapy he perfected was officially recognized by the German FDA.
According to Dr. Gert-Ulf Brillinger, executive secretary of the German Institute for the Evaluation of Molecular Organotherapy, who was in Bangkok recently, rejuvenation therapies can be used for prevention or to treat specific diseases either in isolation, or in combination with medication.
“Basically, what it does is replace a damaged or worn out organ by injections of appropriate cells,” he said. The alternative would be an organ transplant, but with this treatment three is no need for surgery.
Cells are attracted to organs of their own kind and will naturally bond with those in the patient’s body. Theurer found that it was possible to take healthy animal cells and transform them into medication containing pure, specific organ material. This could be injected without the human body’s immune system rejecting it, and rejuvenate the deteriorated organs.
According to Dr. Brillinger, this “fountain-of –youth” dimension of cell therapy is only a part of its importance. It is used to treat or prevent many different conditions in the body from head down to the toes. It is used by athletes as a preventive treatment against the wear and tear on muscle and bone, and it was the therapy of choice for the last coach of Germany’s national soccer team.
One of the most common ailments suffered by older people is arthritis, a painful and disabling disease affecting the joints. Pain killing drugs, cortisone injections and more recently developed methods will give relief from the pain: in other words, they will treat the symptoms. But they won’t affect the source of the pain, and the joint will continue to deteriorate as time and use put more pressure on it.
“Our aim is to treat the cause, which is the deterioration of the cartilage in the joint,” said Dr.Brillinger.
“We’re not trying simply to relieve the pain, but to remove the conditions that caused it by renewing the joints.”
“Arthritis sets in when the cartilage that acts as a cushion between the bones of a joint begins to wear down. The space between the bones in the joint narrows and in time, the bones will rub against one another causing great pain. But with biomolecular therapy, we can restore the cartilage by injection medication into the joint that will thicken the cartilage.”
Two questions immediately leap to mind: where do the new cells come from? And why isn’t everybody using this treatment?
“The donor is likely to be an unborn calf," said Dr.Brillinger. “We can take the cartilage in the fetus of a calf isolate the exact part of it that we need. This is the base of the medication that we inject into the joint. The cells of the new organ will gravitate to the old one and bring new life to it”
“As to why isn’t everybody applying for the therapy, I only wish they were. Right now, there are several thousand registered physicians licensed to provide the treatment to their patients. Its benefits are quite well-known, but in a fairly limited circle.”